How PBI/Gordon Companies leveraged our Sirolimus API Market report
VM Intelligence · Sample preview · Chemicals and Materials · Forecast 2027–2033
Glyphosate Toxicity Market
- By Toxicity Type: Acute Toxicity, Chronic Toxicity, Carcinogenicity, Endocrine Disruption, Neurotoxicity
- By Exposure Route: Oral Exposure, Dermal Exposure, Inhalation Exposure, Ocular Exposure
- By Application Sector: Agricultural Use, Residential Use, Industrial Use, Public Health Use
- By Detection Method: Biochemical Assays, Immunoassays, Chromatographic Techniques, Mass Spectrometry, Biosensors
- By Regulatory Focus: Risk Assessment, Environmental Impact, Human Health Impact, Residue Analysis
Key Highlights
A snapshot of what the full report proves- 01 Market size - $X,XXX.XM global market in 2025 - the verified base-year revenue. Executive Summary →
- 02 Forecast - Full 2033 market projection modelled inside - unlock the forecast value to see where the market lands. Market Outlook →
- 03 Growth - Year-by-year CAGR across 2027–2033 - unlock the growth rate and the full model. Market Outlook →
- 04 Leading segment - Acute Toxicity leads By Toxicity Type at XX% share. Market, by Service Type →
- 05 Global coverage - Sized across 5 regions and 20 countries, each broken out by segment. Market, by Geography →
- 06 Competitive landscape - 15 companies profiled with SWOT, benchmarking and market-share analysis. Company Profiles →
Inside the Report
12 chapters · 298 pages- 01 Introduction Definition, segmentation & scope p.12 →
- 02 Research Methodology How the numbers were built p.20 →
- 03 Executive Summary The market in one chapter p.34 →
- 04 Market Outlook Drivers, restraints, trends p.66 →
- 11 Competitive Landscape 5 sections p.180 →
- 12 Company Profiles 15 players: SWOT & benchmarking p.188 →
Full report · locked preview
Everything inside the Glyphosate Toxicity Market report
A complete, evidence-based study - 12 chapters and 125 sections covering market size, segmentation across 5 axes, regional analysis and 15 company profiles, forecast to 2033.
Segmentation covered
Companies profiled
★★★★★ Excellent
15 players profiled - tiered by revenue contribution, footprint and R&D capability.
ACE Matrix · p.153 →Bayer AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.155 →Corteva Agriscience
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.160 →Nufarm Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.166 →UPL Limited
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.173 →ADAMA Agricultural Solutions Ltd.
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies
Full profile · p.178 →Syngenta AG
Tier 1 · Market Leader
SWOT · Benchmarking · Winning imperatives · Strategies · Key developments
Full profile · p.184 →BASF SE
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.191 →FMC Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.196 →Sumitomo Chemical Co. Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.202 →Mitsui Chemicals Inc.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking · Segment breakdown
Full profile · p.209 →Arysta LifeScience Corporation
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.214 →Sharda Cropchem Ltd.
Tier 2 · Established Specialist
Overview · Insights · Product benchmarking
Full profile · p.220 →Jiangsu Yangnong Chemical Group Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.227 →Nanjing Red Sun Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.232 →Jiangsu Huifeng Agrochemical & Chemicals Co. Ltd.
Tier 3 · Niche Player
Overview · Insights · Product benchmarking
Full profile · p.238 →Market estimates & forecast (USD Million)
Fig. 15 · p.34 →Segment mix, 2033 (% share)
Fig. 16 · p.35 →- Acute Toxicity41.7
- Chronic Toxicity9.3
- Carcinogenicity18.8
- Endocrine Disruption16.6
- Neurotoxicity13.5
Regions, 2025 → 2033 (USD Mn)
§6.1 · p.75 →Top countries, 2033 (USD Mn)
§6.2 · p.78 →Year-over-year growth (%)
§3.12 · p.44 →CAGR by region (%)
Fig. 22 · p.71 →Market share by company, 2033 (%)
Fig. 41 · p.152 →- Bayer AG20.8
- Corteva Agriscience16.5
- Nufarm Limited10.9
- UPL Limited10.2
- ADAMA Agricultural Solutions Ltd.8.8
- Syngenta AG4.9
- Others27.9
Segment contribution to growth (%)
Fig. 18 · p.39 →Competitive positioning (ACE matrix)
Fig. 40 · p.153 →Adoption & penetration (% of addressable)
Fig. 12 · p.31 →Revenue by application (USD Mn)
§5.3 · p.62 →Demand by end-use (USD Mn)
§5.4 · p.66 →Average selling price trend (index, 2025=100)
Fig. 27 · p.58 →Top companies by revenue, 2033 (USD Mn)
Fig. 42 · p.155 →Revenue by region, 2033 (%)
Fig. 20 · p.70 →- North America30.4
- Europe23.9
- Asia Pacific21.4
- Latin America14.4
- Middle East and Africa9.9
8 players benchmarked across 6 dimensions — scored 0–100 from share, portfolio, reach, innovation, financials and installed base. Methodology · §8.1 · p.160 →
Competitive scorecard (score 0–100)
Table 31 · p.161 →| Company | Market share | Product portfolio | Geographic reach | Innovation & R&D | Financial strength | Customer base | Composite |
|---|---|---|---|---|---|---|---|
| Bayer AG | 79 | 88 | 87 | 98 | 76 | 88 | 86 |
| Corteva Agriscience | 91 | 92 | 85 | 91 | 72 | 74 | 84 |
| Nufarm Limited | 64 | 63 | 72 | 77 | 87 | 63 | 71 |
| UPL Limited | 75 | 77 | 62 | 67 | 74 | 75 | 72 |
| ADAMA Agricultural Solutions Ltd. | 71 | 72 | 73 | 62 | 65 | 74 | 70 |
| Syngenta AG | 66 | 49 | 56 | 56 | 58 | 66 | 59 |
| BASF SE | 60 | 61 | 49 | 52 | 54 | 55 | 55 |
| FMC Corporation | 49 | 50 | 37 | 38 | 47 | 50 | 45 |
Vendor positioning (presence × innovation)
Fig. 43 · p.163 →Strengths profile (top 3 players)
Fig. 44 · p.165 →- Bayer AG
- Corteva Agriscience
- Nufarm Limited
Capability coverage
§8.3 · p.168 →| Company | Global delivery | R&D depth | Digital platform | Sustainability | After-sales | Custom solutions |
|---|---|---|---|---|---|---|
| Bayer AG | ✓ | ◐ | ✓ | ✓ | ✓ | ◐ |
| Corteva Agriscience | ✓ | ◐ | ◐ | ✓ | ✓ | ✓ |
| Nufarm Limited | ◐ | ✓ | − | ◐ | ✓ | ◐ |
| UPL Limited | ◐ | ✓ | ◐ | ◐ | ✓ | ◐ |
| ADAMA Agricultural Solutions Ltd. | ◐ | ◐ | ◐ | ◐ | ◐ | ◐ |
| Syngenta AG | ◐ | − | − | ◐ | ◐ | − |
| BASF SE | ◐ | ◐ | ◐ | − | − | − |
| FMC Corporation | − | − | ◐ | − | − | ◐ |
✓ Full ◐ Partial − Limited
Overall competitive index (composite, ranked)
Fig. 45 · p.170 →Competitive tiers
§8.4 · p.172 →Leader2
Set the pace on share, breadth and innovation.
Challenger3
Strong scale, closing on the leaders.
Contender1
Focused players with pockets of strength.
Niche2
Specialists in a single segment or region.
Go-to-market strategy
Land Toxicity Type in North America, then scale across Glyphosate Toxicity Market — a $165M beachhead inside a $2.66B market.
Ideal customer profile (who to sell to)
§GTM 1 · p.190 →Acute Toxicity
Best fit — highest urgency & budget in Toxicity Type.
Chronic Toxicity
Strong fit — clear ROI and a fast path to value.
Carcinogenicity
Emerging fit — growing demand, longer sales cycle.
Market-entry sequence (beachhead → scale)
Fig. GTM 1 · p.192 →Beachhead · 2025–2026
Win Toxicity Type in North America
Concentrated ICP, fastest proof and references.
Expand · 2026–2028
Add Exposure Route & next regions
Repeat the motion in adjacent, look-alike segments.
Scale · 2028–2033
Full-market coverage + Application Sector
Multi-channel, platform & ecosystem plays.
Channel mix (routes to market)
§GTM 3 · p.195 →Positioning & messaging
§GTM 2 · p.194 →For Toxicity Type leaders who need defensible market intelligence, VM Intelligence is the fastest, source-cited way to size, segment and win Glyphosate Toxicity Market — unlike generic, static research.
Live & source-cited
Every figure triangulated from 600K+ sources and traceable.
Ready in minutes
A full, tailored report compiled on demand — not weeks.
Scope you control
Pick the chapters, regions and companies that matter.
GTM funnel & unit economics (conversion · CAC / LTV)
Fig. GTM 2 · p.198 →Investment thesis
Glyphosate Toxicity Market is a durable-growth opportunity — $11.3B by 2033, compounding at 9.2%.
Market opportunity (TAM · SAM · SOM)
Fig. 3 · p.14 →Growth trajectory (USD Million)
Fig. 4 · p.16 →Why invest now
§2.1 · p.10 →9.2% CAGR
Demand compounds through 2033, outpacing GDP across Toxicity Type.
Global tailwinds
North America leads today; fastest gains coming from emerging regions.
Structural shift
Adoption in Toxicity Type moving from early to mainstream — durable secular demand.
Consolidation upside
15+ players, no runaway leader — room to build scale and roll up share.
Investment highlights
§2.2 · p.12 →Return scenarios (2033 market value)
Fig. 6 · p.22 →Key risks & mitigants
§9.1 · p.180 →- Input-cost volatilityLong-term supply contracts & hedging
- Regulatory / policy shiftsDiversified exposure across 5 regions
- Technology disruptionR&D pipeline & Exposure Route optionality
- Customer concentrationBroaden installed base beyond top accounts
Board pack · executive summary
Glyphosate Toxicity Market — a $9.07B market by 2033. Plan: grow share from 10.8% to 17.9%.
Strategic scorecard (current vs 2033 target)
Table 1 · p.6 →| Objective | Current | Target · 2033 | Status |
|---|---|---|---|
| Market share | 10.8% | 17.9% | Ahead |
| Revenue | $1.07B | $1.62B | On track |
| Geographic coverage | 2 of 5 regions | 5 of 5 regions | On track |
| Segment coverage | 3 of 5 axes | 5 of 5 axes | Behind |
| Gross margin | 29.1% | 41.9% | Behind |
| Customer retention | 84.2% | 94.8% | At risk |
Where to play (strategic priorities)
§1.2 · p.8 →Lead segment
Win in Toxicity Type
Largest revenue pool and fastest secular demand — concentrate to build share here first.
Geographic
Expand across North America & beyond
Deepen the leading region, then scale into the fastest-growing emerging markets.
Adjacency
Build Exposure Route capability
A defensible second engine — invest in Exposure Route to widen the moat and cross-sell.
Strategic roadmap (2025–2033)
Fig. 1 · p.10 →Phase 1 · Foundation
2025–2027
- Secure core Toxicity Type share
- Fix unit economics
- Stand up data & ops
Phase 2 · Scale
2028–2030
- Enter new regions
- Launch Exposure Route
- Selective M&A
Phase 3 · Lead
2031–2033
- Category leadership
- Premium mix & margin
- Platform & ecosystem
Board decisions & asks
§1.4 · p.14 →- Approve $195M capacity & capability investment
- Greenlight bolt-on M&A in Exposure Route
- Authorise North America expansion plan
- Fund R&D program for Toxicity Type leadership
Risk watchlist (RAG)
§9 · p.180 →- Demand / macro slowdownAhead
- Competitive share lossBehind
- Input-cost & supply riskBehind
- Regulatory / policy changeAt risk
- Execution & talentBehind
Sales deck · value proposition
Win the Glyphosate Toxicity Market conversation — a $6.57B market you can size, segment and defend in minutes.
Who buys (target personas)
§1.1 · p.4 →Product / BU leader
Head of Toxicity Type
Goal Grow share in Toxicity Type
Pain Blind spots on demand, pricing & competitors.
Regional GM
North America lead
Goal Prioritise the right markets
Pain No granular, country-level view of the market.
M&A / strategy
Strategy & Corp Dev
Goal Find where to invest or acquire
Pain Slow, inconsistent third-party research.
From pain to solution
§1.2 · p.6 →The business case (ROI)
Fig. 2 · p.9 →Why buyers trust it (proof points)
§1.3 · p.12 →Coverage includes
Objection handling
§1.4 · p.14 →“We already have market data.”
This triangulates 600K+ sources into one current, defensible view — not another silo.
“How do we know it’s accurate?”
Analyst-reviewed, and every figure is source-cited and traceable to its origin.
“It’s not in the budget.”
A fraction of a single analyst-day — and it pays back on the first decision it informs.
“We need it tailored to us.”
Choose the chapters, regions and companies before you build — you only pay for scope.
What you get (packages)
§1.5 · p.16 →Report
- Full multi-chapter report
- Market size, share & forecast
- Segment & regional breakdowns
- PDF + editable Excel + PPT
Report + Add-ons
- Everything in Report
- Interactive Visualizer
- Competitive benchmarking
- Investor / board / sales decks
Enterprise
- Multiple reports & markets
- Team seats & sharing
- Analyst support & custom scope
- API / data-feed options
Almost there
Access your Glyphosate Toxicity Market report
Sign in to unlock the full report - it’s compiled live and ready in minutes.
Your report is ready to access
Glyphosate Toxicity Market Report is ready
Verify your email to unlock it. We sent a 6-digit code to your inbox.
That code is invalid or expired. Please try again.
Trusted by strategy, finance & consulting teams
Related Reports
Chemicals and Materials · scroll →High Temperature SCR Catalysts Market
Market size, share, segmentation and regional forecast.
$1.8B market · 2025 base year
View reportOpen Versus Closed Cell Phenolic Foams Market
Market size, share, segmentation and regional forecast.
$4.5B market · 2025 base year
View reportParaffin Wax Machine Market
Market size, share, segmentation and regional forecast.
$4.1B market · 2025 base year
View reportHigh Temperature Resistor Market
Market size, share, segmentation and regional forecast.
$6.0B market · 2025 base year
View reportHigh Temperature Resistant Zirconia Fiber Market
Market size, share, segmentation and regional forecast.
$2.9B market · 2025 base year
View reportPolyester Staple Fiber & Nylon Staple Fibers Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportHigh Temperature Resistant Wire Market
Market size, share, segmentation and regional forecast.
$4.7B market · 2025 base year
View reportHigh Temperature Resistant Thermal Silicone Sheet Market
Market size, share, segmentation and regional forecast.
$5.3B market · 2025 base year
View reportPolyester Staple Fiber and Rasin Market
Market size, share, segmentation and regional forecast.
$2.7B market · 2025 base year
View reportHigh-temperature Resistant Terminal Blocks Market
Market size, share, segmentation and regional forecast.
$5.1B market · 2025 base year
View reportHigh Temperature Resistant Tape Market
Market size, share, segmentation and regional forecast.
$3.3B market · 2025 base year
View reportHigh Temperature Resistant Spandex Fabric Market
Market size, share, segmentation and regional forecast.
$4.8B market · 2025 base year
View reportThe showdown
Custom-built vs. off-the-shelf
Scroll to watch them go head-to-head
- Tailored to your exact scope
- Delivered in minutes
- Live, always-current data
- Fully editable data (XLSX)
- You choose the companies
- Source-cited & traceable
- Generic, one-size template
- Waits 2–5 days
- A fixed snapshot in time
- Locked, flat PDF
- Preset company list
- Opaque sourcing
Customer Testimonials
Proof from industry leaders who rely on us
These stories come from the executives who depend on VMR’s intelligence for market entry, expansion, assessment, and planning. Their outcomes and experiences reflect our commitment to clarity.
In their words
Watch clients tell their story
How VMR helped University of Limerick with Anesthesia Monitoring Devices
How VMR helps brands expand into Africa & emerging markets
Unlock your GTM strategy: an Elsewedy Electric success story
Beyond sales data: layering NielsenIQ data to support strategy
How VMR became the trusted partner for United Alloy